WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced ...
Teleflex TFX recently announced the upcoming full market release of the Advanced Tissue Control (“ATC”) feature on its unified UroLift 2 System — a platformdesigned for the treatment of benign ...
Teleflex Incorporated TFX recently unveiled the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System together with real-world data presentations at the American Urological Association ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Sponsored content: Enlarged prostate affects ...
PLEASANTON, Calif., Feb. 19, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
PLEASANTON, Calif., June 17, 2020 /PRNewswire-PRWeb/ -- NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today ...
Five Studies Show Significant Relief and Improved Quality of Life with UroLift System The “Real-World Experience” study, which enrolled 156 patients at the Norfolk & Norwich University Hospital in the ...
UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France
A surgical option which is minimally invasive and available as same-day outpatient procedure1,2,3 Following a positive Haute Autorité de Santé (HAS) assessment, a procedure code has been granted ...
Data Presented at American Urological Association 2020 Virtual Experience Highlight Benefits and Superior Sexual Function* Preservation of the Minimally Invasive Treatment for Patients with Enlarged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results